GlassScriptPhysician profile
Glyn E Lewis
NPI 1407831993
$884.93
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $211 · 2021: $265.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $327.95 | 2019-2021 | |
| Smith+Nephew, INC. | $129.78 | 2019-2021 | |
| Osteomed LLC | $66.61 | 2019 | |
| Wright Medical Technology, INC. | $46.87 | 2019 | |
| Depuy Synthes Sales INC. | $28.05 | 2020 | |
| Abbott Laboratories | $27.71 | 2020 | |
| Kerecis Limited | $26.72 | 2019 | |
| Bioventus LLC | $25.82 | 2021 | |
| Grt US Holding, INC. | $23.04 | 2021 | |
| Kci USA, INC. | $20.66 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.41 | 2019 | |
| Integra Lifesciences Corporation | $17.65 | 2021 | |
| Metric Medical Devices, INC. | $17.60 | 2019 | |
| Next Science LLC | $14.14 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.99 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $12.52 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.31 | 2021 | |
| Acell, INC. | $11.75 | 2019 | |
| Merck Sharp & Dohme LLC | $11.24 | 2019 | |
| Reprise Biomedical, INC. | $10.87 | 2021 | |
| Orthofix Medical, INC. | $10.15 | 2019 | |
| Dynasplint Systems INC. | $10.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glyn Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.